January 27, 2011 The Food and Drug Administration is not willing to expand the approval of an existing drug for enlarged prostates as a means to reduce the risk of prostate cancer. A panel of expert previously recommended against the expansion.
Metastatic breast cancer cells found in a lymph node.
National Cancer Institute
January 3, 2011 An experimental plastic chip could be used to find even a few cancer cells floating in the blood. Now the health products giant Johnson & Johnson is investing in the technology being developed at a Boston hospital.
Some scientists doubt the findings of a report that suggests widespread chromium contamination of drinking water.
December 22, 2010 The Environmental Working Group has sounded the alarm on chromium contamination of drinking water of 31 American cities with a new report. But some experts have expressed doubt about the study and its implications for consumers.
December 16, 2010 The Food and Drug Administration says data from recent clinical studies show the benefits of the drug Avastin for breast cancer patients don't outweigh the risks. Roche's Genentech unit disagrees and wants to keep marketing the drug for that use.
The EPA dropped saccharin from its official list of hazardous substances.
December 15, 2010 Decades after cancer worries landed saccharin on the Environmental Protection Agency's list of hazardous chemicals, the regulators have said it's not a risk. More research showed the original fears were unfounded.
Aspirin may add cancer-fighter to its list of uses.
December 7, 2010 A British study offers compelling -- though not clinching -- evidence that the humble aspirin tablet can prevent death from many kinds of cancers, if you take the medicine long enough in middle age.
November 22, 2010 Ten years ago, the clinical staging prostate cancer test was supposed to help doctors decide how to treat it. New evidence shows the test is not a good predictor of how serious the disease is.
November 16, 2010 An analysis of Medicare data finds many cancer patients are getting aggressive care toward the end of life. The intensive approach might not be best for them and adds to the drain on Medicare's budget.
Army Captain William Krueger studies CT scans at the National Naval Medical Center in Bethesda, Md.
CWO4 SETH ROSSMAN/NAVY VISUAL NEWS SERVICE
November 5, 2010 The 20 percent mortality reduction found for lung CT screening for heavy smokers is in the same ballpark as the probable benefit from mammograms – which reduce breast cancer deaths by 10 to 30 percent, depending on the age of those screened.
November 4, 2010 A federally funded study provides evidence that a screening test may help fight the nation's top cancer killer. The study, involving heavy smokers, showed CT scans cut deaths by 20 percent. Even so, the approach isn't ready for routine use.
<iframe src="http://www.npr.org/player/embed/131070579/131075727" width="100%" height="290" frameborder="0" scrolling="no">
October 20, 2010 New information on the increased risk of dying of breast cancer for women taking hormone replacement therapy has women and their doctors once again re-evaluating whether taking a popular drug is worth the risk.
October 19, 2010 The number of cancer patients who need radiation therapy is expected to increase by 22 percent by 2010. But radiation oncologists are only projected to increase by 2 percent.
Does a woman diagnosed with breast cancer need more mammograms?
October 12, 2010 Even though the benefits are scant, many already terminally ill cancer patients get screened for additional cancers, a study finds. The tests get done out of habit and a lack of discussion between doctors and patients, the researchers suggest.
Moderate exercise five days or more each week is one ingredient for reducing breast cancer risk.
October 12, 2010 Researchers found women had a lower risk of breast cancer later in life when they exercised regularly, drank modestly and kept a normal body weight. There are benefits even if a woman's mother or sister had developed breast cancers.
September 28, 2010 Provisions of the federal health law boost research by the National Institutes of Health on breast cancer in young women and fund awareness campaigns for breast health. The overhaul provides $9 million a year through 2014.
NPR thanks our sponsors
Become an NPR sponsor